New diabetes clinical trial: JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D

Published on: 2026-09-29T04:00:00Z
Conditions: T1DM - Type 1 Diabetes Mellitus
Interventions: Drug: Ivarmacitinib; Drug: Placebo
Sponsors: Huijie Zhang
Not yet recruiting
https://ift.tt/6qngTmB